Skip to Content
Merck
CN

Key Documents

View All Documentation

EMU040081

MISSION® esiRNA

targeting mouse Hook2

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

NACRES:
NA.51
UNSPSC Code:
41105324
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

description

Powered by Eupheria Biotech

Quality Level

100

product line

MISSION®

form

lyophilized powder

esiRNA cDNA target sequence

TTGGCGAGTTCTCAAATCCTGCAGAACTCGGCAAACTGCTTCAGTTGGTACTGGGCTGTGCTATCAGTTGTGAGAAAAAACAGGAGTATATCCAAAGAATTATGACCCTGGAGGAGTCTGTTCAACATGTAGTGATGGAAGCCATCCAGGAGCTCATGACCAAAGACGCTCCTGATTCCCTGTCACCAGAGAATTACGGGAATTTTGATACACAGTCCCGCAGGTACTATTTCCTGAGTGAGGAGGTGGAGGAGGGTGATCATCTTCAGCAACATTACCTGGATCTGGAGCGCCAGCTCTTGCTCCTTTCAGAGGAGAAGCAGAATCTGGCACAAGAGAACGCTGCCCTTCGAGAGAGGGTGGGCCGTTCGGAAGTGGAGAGTGCCCCGGGCCTCACAGCTAAGAAGCTATTGCTTCTGCAGTCACAGCTAGAACAGCTTCAAGAGGAGAATTTCAGGCTGGAGAGTAGCCGGGAAGATGATCGGCTACGCTGCCTGGAACTAGAGCGTGAGGTCG

Ensembl | mouse accession no.

ENSMUSG00000052566

NCBI accession no.

NM_133255

shipped in

ambient

storage temp.

−20°C

Gene Information

mouse ... HOOK2(170833), Hook2(170833)

General description

MISSION® esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence. These multiple silencing triggers lead to highly-specific and effective gene silencing.

For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.

Legal Information

MISSION is a registered trademark of Merck KGaA, Darmstadt, Germany

Storage Class

12 - Non Combustible Liquids

flash_point_f

Not applicable

flash_point_c

Not applicable

Regulatory Information

新产品

This item has

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
AOR
QCS

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Baobiao Zhuo et al.
Biochemical and biophysical research communications, 464(2), 401-406 (2015-06-28)
Accumulating evidence has shown that PI3K/Akt pathway is frequently hyperactivated in osteosarcoma (OS) and contributes to tumor initiation and progression. Altered phenotype of glucose metabolism is a key hallmark of cancer cells including OS. However, the relationship between PI3K/Akt pathway

Global Trade Item Number

SKUGTIN
EMU040081-20UG04061828499953
EMU040081-50UG04061828274321